Zithromax associated with cardiovascular deaths; FDA reviewing
FDA has notified healthcare professionals that it is aware of a study published in the New England Journal of Medicine (Azithromycin and the Risk of Cardiovascular Death) reporting a small increase in cardiovascular deaths and in the risk of death from any cause in persons treated with a 5-day course of azithromycin (Zithromax) compared to persons treated with amoxicillin, ciprofloxacin, or no drug. FDA said that it is reviewing the results from this study and will communicate any new information on azithromycin and on this study or on the potential risk of QT interval prolongation after the agency has completed its review.
Sudden Cardiac Arrest and Death Following Shocks From a TASER Electronic Control Device: It can Happen!
This article reports 8 cases of TASER X26 ECD–induced loss of consciousness in which first recorded rhythms were ventricular tachycardia/fibrillation in 6 and asystole.
CDC: Test All 'Boomers' for Hepatitis C Infection
Long-Term Outcomes of Mechanical Valve Replacement in Patients With Atrial Fibrillation
House Energy and Commerce Committee Approves FDA Bill: Enhanced Notification
Plavix Generic Competitors Get Green Light
Coffee Linked to Lower Death Risk
Laxative-Free Scans Work Almost as Well as Colonoscopies
Medicare’s no-pay rule sharpens infection-control efforts
Family Debate -- Buy a Car or a Year of Healthcare?
Acute kidney injury: Prevention of contrast-induced AKI—the ongoing saga
Biologic Works as Monotherapy in Early RA
In Some Brain Bleeds, Patients Do Better at High-Volume Hospitals
Treatment of refractory catatonic schizophrenia with low dose aripiprazole
Prices for doctor services lag behind inflation
Concussions May Be More Severe in Girls and Young Athletes
Progress Made on How Medicare Pays Doctors
Infections cause one in six cancer cases
Study: Savings and risks in health insurance trend
Fertility Methods Raise Risk of Birth Defects
OTC rule ‘significantly’ cuts into time for sick patients
More than 100 charged in massive Medicare fraud busts in 7 cities in scams totaling $452 mil
Macrolide Antibiotics Improve Survival in Patients With Acute Lung Injury
Malpractice: An Effective Ray of Hope for Doctors
Between lawsuits and high premiums, the malpractice climate seems like gloom and doom. One effort to improve the situation, which is having moderate success, has been to raise the bar for expert witnesses.
Mass. Senate OKs version of health care bill
The Massachusetts Senate passed its version of a health care cost reduction bill Thursday night, aimed at trimming projected health care costs in the state by $150 billion over the next 15 years.
Drug for Heavy Menses More Effective With Increasing Age
Oral tranexamic acid tablets at a dose of up to 3.9 g/day reduced blood loss by a mean of at least 60-65 mL per menstrual period in women aged 30 or older with heavy menstrual bleeding, a pooled analysis of two pivotal trials found.
A man presents with dyspnoea and recurrent fever of unknown origin
Noncalcified Atherosclerotic Plaque Burden at Coronary CT Angiography: A Better Predictor of Ischemia at Stress Myocardial Perfusion Imaging Than Calcium Score and Stenosis Severity
A 55‐y/o male with a history of hypertension and smoking, presented with severe acute onset central chest pain
You are viewing the text version of this site.
To view the full version please install the Adobe Flash Player and ensure your web browser has JavaScript enabled.
Need help? check the requirements page.